Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Chao-Ying Qi"'
Autor:
Gui-Xing Chen, Chao-Ying Qi, Wen-Jie Hu, Xiao-Hui Wang, Yun-Peng Hua, Ming Kuang, Bao-Gang Peng, Shao-Qiang Li
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background The influence of perioperative blood transfusion (PBT) on postsurgical survival of patients with different stage of hepatocellular carcinoma (HCC) is not well clarified. This study aimed to evaluate the impact of PBT on survival o
Externí odkaz:
https://doaj.org/article/389fa27ae8334befad0e5dbc141e4716
Autor:
Wei Fan, Chao-Ying Qi, Heng Liu, Bo Cheng, Zhen-Dong Wang, Jing-Jing Pan, Pei Feng, Jun-Gui Liu
Publikováno v:
World Journal of Gastrointestinal Surgery
Pancreatic head carcinoma (PHC) is one of the common gastrointestinal malignancies with a high morbidity and poor prognosis. At present, radical surgery is still the curative treatment for PHC. However, in clinical practice, the actual R0 resection r
Autor:
Weihua Li, Jing-Jing Pan, Wei Fan, Fengyuan Man, Heng Liu, Lei Zhang, Pei Feng, Chao-Ying Qi, Bing Liu
Background: The clinical and CT manifestations of COVID-19 pneumonia and non-COVID-19 pneumonia in the same period have not been compared in detail. The purpose of this study is to analyze the clinical and CT manifestations of COVID-19 pneumonia and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2c45750b6fe384e18d9b27953e6d04c
https://doi.org/10.21203/rs.3.rs-27288/v1
https://doi.org/10.21203/rs.3.rs-27288/v1
Autor:
Xiao-Hui Wang, Baogang Peng, Shao-Qiang Li, Chao-Ying Qi, Ming Kuang, Yunpeng Hua, Gui-Xing Chen, Wen-Jie Hu
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Background The influence of perioperative blood transfusion (PBT) on postsurgical survival of patients with different stage of hepatocellular carcinoma (HCC) is not well clarified. This study aimed to evaluate the impact of PBT on survival outcomes o
Autor:
Wei-Kai Xiao1 xiaowk@mail2.sysu.edu.cn, Chao-Ying Qi2 weik1206@163.com, Dong Chen1 chiduoleyx@163.com, Shao-Qiang Li1 lishaoqiang9@163.com, Shun-Jun Fu1 499780107@qq.com, Bao-Gang Peng1 1356037070714@139.com, Li-Jian Liang1 ljsyx@163.com
Publikováno v:
BMC Cancer. 2014, Vol. 14 Issue 1, p1-20. 20p.
Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection
Publikováno v:
Surgery. 154:536-544
Background Glypican-3 (GPC3), an oncofetal protein, is overexpressed in hepatocellular carcinoma (HCC). The diagnostic efficacy of GPC3 for HCC has been evaluated intensively in recent years; however, the prognostic value of GPC3 for HCC has not been
Autor:
Shao-Qiang, Li, Jie, Lin, Chao-Ying, Qi, Shun-Jun, Fu, Wei-Kai, Xiao, Bao-Gang, Peng, Li-Jian, Liang
Publikováno v:
Hepato-gastroenterology. 61(130)
DNA-based tumor vaccine immunotherapy which elicits exclusively cellular immune response against cancer cells in an antigen-specific fashion has been documented to be an effective treatment for cancers in the past decade. Glypican 3 (GPC3) is especia
Autor:
Shao-Qiang Li, Dong Chen, Shun-Jun Fu, Chao-Ying Qi, Wei-Kai Xiao, Li-jian Liang, Bao-Gang Peng
Publikováno v:
BMC Cancer
Backgrounds Glypican-3(GPC3) has been implicated in tumor development and progression for several years. However, the prognostic significance of GPC3 expression in patients with hepatocellular carcinoma (HCC) is controversial. We performed a meta-ana
Publikováno v:
PeerJ, Vol 8, p e8312 (2020)
Background Lower grade glioma (LGG) are a heterogeneous tumor that may develop into high-grade malignant glioma seriously shortens patient survival time. The clinical prognostic biomarker of lower-grade glioma is still lacking. The aim of our study i
Externí odkaz:
https://doaj.org/article/16272e82bbcb4152a53f64e437e6a971